<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20121020011172N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-04</date_registration>
      <primary_sponsor>Cognitive Sciences &amp; Technologies Council</primary_sponsor>
      <public_title>Examining the effect of electrical brain stimulation on food cue-induced craving by MRI</public_title>
      <acronym></acronym>
      <scientific_title>Modulation of Psychological and Neural Response for Food Craving among People with Obesity Using Transcranial Direct Current Stimulation (tDCS) on Dorsolateral Prefrontal Cortex (DLPFC): A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>65</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45482</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Basic scienece, Randomization description: Randomization will be a randomized block design with 6 blocks, the sequence of randomization will be determined through sealedenvelope.com site and based on this, the researcher considers eligible subjects for the two study groups, Blinding description: The subject and researcher is not aware of the actual or sham stimulation. In fact, the screen of the device is the same in both cases (real stimulation or sham) and only the supervisor is aware of the type of intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Food craving and obesity.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group (active tDCS): The current level used for the study will not exceed 2mA. The stimulator ramps up the current over 30 seconds. In the sham setting, the current is ramped down again. In the real setting, the current stays at the same level. The stimulation will proceed for 20 minutes, at which point the current is slowly ramped down over 30 seconds. Intervention 2: Control group (sham tDCS): The stimulator ramps up the current over 30 seconds and then the current is slowly ramped down over 30 seconds. The set-up for sham and real stimulation sessions are exactly the same.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The process of publication will be specified.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Hamed Ekhtiari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Laureate Institute for Brain Research 6655 South Yale Avenue</address>
        <city>Tulsa</city>
        <country1>United States of America</country1>
        <zip>74136-3326</zip>
        <telephone>001 918 502 5100</telephone>
        <email>hekhtiari@laureateinstitute.org</email>
        <affiliation>Laureate Institute for Brain Research</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Hamed Ekhtiari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Laureate Institute for Brain Research 6655 South Yale Avenue</address>
        <city>Tulsa</city>
        <country1>United States of America</country1>
        <zip>74136-3326</zip>
        <telephone>001 918 502 5100</telephone>
        <email>h.ekhtiari@gmail.com</email>
        <affiliation>Laureate Institute for Brain Research</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Age ≥18 and &lt;61 years old2. Persian speaking3. BMI: 25-354. Frequent food cravings (≥3times/day during last month) in the screening self-report5. Positive response to food cue-reactivity screening (≥ 50% craving in visual analog scale)6. Willing and capable of interacting with the informed consent process</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>61 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Unwillingness or inability to complete any of the major aspects of the study protocol, including magnetic resonance imaging (i.e., due to claustrophobia), food cue rating, or behavioral assessment.2. Comorbid severe psychiatric disorders (e.g.  severe depression, bipolar, psychosis or background of suicide) Which is evaluated by a specialist.3. Active suicidal ideation with intent or plan determined by self-report or assessment by PI or study staff during the initial screening or any other phase of the study 4. Any active skin disorder that affects skin integrity of the scalp 5. Unstable medical disorder reported in subject’s medical history or by a clinician assessment6. Non-correctable vision or hearing problems7. History of brain injury or seizure 8. History of any brain stimulation 9. Any other condition the PI or study staff feel would put the subject at risk for entering the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Overweight and obesity</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group (active tDCS): The current level used for the study will not exceed 2mA. The stimulator ramps up the current over 30 seconds. In the sham setting, the current is ramped down again. In the real setting, the current stays at the same level. The stimulation will proceed for 20 minutes, at which point the current is slowly ramped down over 30 seconds.</i_keyword>
      <i_keyword>Control group (sham tDCS): The stimulator ramps up the current over 30 seconds and then the current is slowly ramped down over 30 seconds. The set-up for sham and real stimulation sessions are exactly the same.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood oxygen level dependent (BOLD) signal changes in the contrast between food and non-food images. Timepoint: Before and after of intervention. Method of measurement: BOLD signal differences with voxel-wise analysis in the regions of interests (ROIs) (Prefrontal cortex, Insula, Striatum, Thalamus and Extended Amygdala) in craving &gt; neutral contrast in event-related design food cue exposure fMRI task.</prim_outcome>
      <prim_outcome>Food Craving Self-Report. Timepoint: Before and after of intervention. Method of measurement: Subjective response to "On a scale of 0-100, How much "food craving" are you experiencing RIGHT NOW" measured on a visual analog scale (0-100).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Cortical-Subcortical Connectivity in Resting State fMRI. Timepoint: Before and after of intervention. Method of measurement: Correlation between resting-state average Blood oxygen level dependent (BOLD) signal time series in subcortical ROIs and voxels within prefrontal cortex and Insula.</sec_outcome>
      <sec_outcome>Cortical-Subcortical Task-based Connectivity in Cue Exposure fMRI. Timepoint: Before and after of intervention. Method of measurement: Psychophysiological Interaction (PPI) between average blood oxygen level dependent (BOLD) signal time series in subcortical ROIs and voxels within prefrontal cortex and Insula measured before and after tDCS (active and sham).</sec_outcome>
      <sec_outcome>RAI )Allocation Index (RAI) in Resting State fMRI. Timepoint: Before and after of intervention. Method of measurement: The correlation among default mode network (DMN), saliency network (SN) and Executive Control Network (ECN) in resting state fMRI.</sec_outcome>
      <sec_outcome>Area Under Electrode Connectivity in Resting State fMRI. Timepoint: Before and after of intervention. Method of measurement: Voxel-wise Psychophysiological Interaction (PPI) between average blood oxygen level dependent (BOLD) signal in the cortical area under the Anode electrode and whole brain in craving &gt; neutral contrast in event-related designfood cue exposure fMRI task.</sec_outcome>
      <sec_outcome>Food Craving Control Self-Report. Timepoint: Before and after of intervention. Method of measurement: Subjective response to "On a scale of 0-100, How much "control" do you feel you have over your "food craving" RIGHT NOW?".</sec_outcome>
      <sec_outcome>Desire for Food Self Report. Timepoint: Before and after of intervention. Method of measurement: Response to the Food Craving Questionnaire (FCQ).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Cognitive Sciences &amp; Technologies Council</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-02-12</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, 1449614535, IRAN Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
